Peptides · Evidence-graded entry

GHK-Cu (copper tripeptide-1): what the evidence shows

Name: GHK-Cu (copper tripeptide-1): what the evidence shows
Creator: SoftMaxx AI Editorial
Published: 2026-09-30

GHK-Cu, evidence-graded: the best support is small human studies. Citations checked against PubMed and regulator records; doses studied, FDA status.

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed · How we grade evidence

SoftMaxx AI sells no peptides and takes no vendor money.

The verdict · strongest evidence Human, small or uncontrolled

Human, small or uncontrolled GHK-Cu has strong cell and animal data but thin human evidence. It raised collagen in cultured fibroblasts and in rat wound chambers. A 2025 review notes a 'surprising absence of clinical studies'; a 2026 systematic review calls the human literature 'thin and fragmented', with most randomized trials small; and a second 2026 review lists a 13-person post-laser study that was negative on objective measures and an 18-person eyebrow study.^{[1][2][3][4][5]}

What GHK-Cu is

GHK (glycyl-L-histidyl-L-lysine) is a three-amino-acid peptide with an affinity for copper(II) ions that was isolated from human plasma ^[1]; GHK-Cu is its copper complex. The EU cosmetic-ingredient database (CosIng) lists copper tripeptide-1 as 'a copper complex of Tripeptide-1' (CosIng entry) and gives palmitoyl tripeptide-1 the chemical name N-(1-oxohexadecyl)glycyl-L-histidyl-L-lysine (CosIng entry), so tripeptide-1 is GHK and copper tripeptide-1 is GHK-Cu. A 2025 review says GHK-Cu and Pal-GHK are widely used in anti-wrinkle products on the cosmetic market ^[3]. GHK-Cu is also sold as an injectable: Health Canada lists GHK-Cu among unauthorized injectable peptides it has seized ^[7]. The topical cosmetic ingredient and the injected product are very different things with very different evidence.

Pal-GHK (palmitoyl tripeptide-1) is the palmitoylated form of GHK ^[3] and one of the two peptides present in Matrixyl 3000 ^[6].

Animal In fibroblast cultures, GHK-Cu raised collagen synthesis; the effect began at picomolar levels and peaked at 1 nanomolar ^[1]. In rat wound chambers, GHK-Cu raised collagen, glycosaminoglycan and total protein content ^[2]. A 2026 systematic review describes copper as a cofactor for the lysyl oxidase enzymes that cross-link collagen ^[4]. The claim that GHK changes the activity of at least 4,000 human genes is a statement in a 2015 review ^[8]; a gene count is not a skin outcome.^[1][2][4][8]

Claims vs. evidence

Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.

Claim as marketedReduces fine lines/wrinkles and improves firmness (topical)Human, small or uncontrolled A 2026 review calls the clinical evidence sparse. The human studies it lists are small: a 13-person study after laser resurfacing that was negative on objective measures, and an 18-person split-face eyebrow study that reported positive cosmetic hair outcomes; it calls older cosmetic reports small or incompletely characterized ^[5]. A 2026 systematic review says most randomized trials are small and tested facial creams ^[4], and a 2025 review notes a 'surprising absence of clinical studies' ^[3]. One published case report describes a single man who used GHK-Cu with four other actives and a resurfacing device ^[9].^[5][4][3][9]
Claim as marketedStimulates collagen productionAnimal Collagen rose in fibroblast cultures and in rat wound chambers. In people, a single-patient case report found more collagen in biopsies after GHK-Cu was used with four other actives and a device; with no comparison product, the effect cannot be credited to GHK-Cu.^[1][2][9]
Claim as marketedWound healing / post-procedure repairAnimal Rat wound-chamber data, plus wound models in dogs, mice and pigs described in a 2015 review. A phase 2 acute-wound study in people (NCT07437586) was still recruiting, with no efficacy results, when a 2026 review was written.^[2][8][5]
Claim as marketedHair growth / thicker hairHuman, small or uncontrolled (5-ALA + GHK complex data) A copper-binding peptide, PC1031, enlarged hair follicles on the backs of fuzzy rats, an effect the authors called similar to topical minoxidil ^[10]. AHK-Cu, a related copper tripeptide, lengthened human hair follicles kept alive in a dish ^[11]. In a related human study, a placebo-controlled trial in 45 men (its abstract does not say whether it was randomized) tested a complex of 5-aminolevulinic acid and GHK once daily for 6 months, and hair counts rose more on both strengths than on placebo; the paper names GHK, not GHK-Cu, and the complex has a second active, so the result cannot be credited to GHK-Cu ^[12].^[10][11][12]
Claim as marketedInjectable or microneedled GHK-Cu gives systemic anti-aging / 'glow'No supporting study For injected GHK-Cu, FDA says there are limited data in humans to inform safety ^[13]. A 2026 systematic review says microneedles raised GHK-Cu skin uptake in lab and pig-skin models, but this route has yet to be evaluated in a registered, adequately powered human randomized trial published in the peer-reviewed literature ^[4].^[13][4]
Claim as marketed'Resets' thousands of genes to a younger stateExpert review The figure (at least 4,000 human genes turned up or down, 'essentially resetting DNA to a healthier state') is a statement in a 2015 review ^[8], and a 2018 review links GHK's actions to new gene data ^[14]. Neither abstract ties the gene figure to a skin outcome measured in people.^[8][14]

Common myths, checked

Common beliefGHK-Cu is clinically proven to regrow collagen and erase wrinkles.Animal The collagen data come mainly from cell culture and rat wound chambers; the one human biopsy report we found is a single case in which GHK-Cu was used with four other actives and a device. A 2025 review notes a 'surprising absence of clinical studies' of GHK-Cu in anti-wrinkle products, and a 2026 systematic review says most randomized trials in people are small.^{[1][2][3][4][9]}
Common beliefInjecting GHK-Cu works better than putting it on skin.Regulator document FDA says there are limited data in humans to inform the safety of injected GHK-Cu, and it flags possible immune reactions from aggregation and peptide-related impurities. We found no trial comparing injected with topical GHK-Cu.^[13]
Common beliefCopper peptides penetrate deep into skin easily.In vitro (cells) A 2025 review describes GHK-Cu as fairly hydrophilic, with limited permeation through the skin's outer layer ^[15]; another 2025 review calls it relatively skin permeable ^[3]. In a lab test on excised human skin, under an unlimited-dose setup for 48 hours, copper from GHK-Cu crossed the skin in amounts the authors called potentially effective for inflammatory disease ^[16]. A thin serum layer is a much smaller dose.^[16][15][3]
Common beliefCopper peptides are as good as minoxidil for hair.Human, small or uncontrolled For copper peptides we found rat and follicle-in-a-dish data, and a 2026 review lists an 18-person split-face eyebrow study of GHK-Cu; we found no human scalp hair-count trial of GHK-Cu. Minoxidil has human trials: a 2022 network meta-analysis compared minoxidil, finasteride and dutasteride across 23 studies in men with pattern hair loss.^{[10][11][17][5]}

Doses used in studies (not a recommendation)

These are the amounts given to the people, animals or cells in the cited studies, copied as reported. They are a record of what was tested, not dosing instructions, and nothing here says what you should take.

Studied in	Route	Amount reported	How often	How long	n	Source
Humans	topical (with Jet-M microdroplet resurfacing device)	concentration not stated in abstract (multi-ingredient solution)	once weekly	12 weeks	1	^[9] one 59-year-old man (case report)

Side effects and risks

Expert review Gray-market injectables: uncertain identity, purity, potency and sterility; a 2026 review also cites contamination and inaccurate dosing^[18][19]
Regulator document Unauthorized injectable peptides (Health Canada names GHK-Cu among them): infections, allergic reactions and other serious complications^[7]
Case report Topical use: no adverse effect during or after use in a single-patient case report^[9]

Regulatory status (checked 2026-09-30)

United States (FDA)We found no FDA-approved product containing GHK-Cu in Drugs@FDA (searched 2026-10-01). (FDA: Drugs@FDA search: ghk-cu — no approved product found) FDA lists GHK-Cu (except for injectable routes of administration) in 503A Category 1, “Bulk Drug Substances Under Evaluation” (list updated 2026-05-14). (FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act)
CanadaWe found no product containing GHK-Cu in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada: Health Canada Drug Product Database search: ghk-cu — no product found) Health Canada named GHK-Cu in “Think twice before injecting peptides bought online: unauthorized products can seriously harm you”. (Health Canada: Think twice before injecting peptides bought online: unauthorized products can seriously harm you) Health Canada named GHK-Cu in “Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks”. (Health Canada document) Health Canada named GHK-Cu in “Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks”. (Health Canada document) Health Canada named GHK-Cu in “GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients”. (Health Canada document)
Sport (WADA)WADA’s Prohibited List does not name GHK-Cu. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether GHK-Cu is one of them. (WADA: World Anti-Doping Code International Standard Prohibited List 2026; WADA: World Anti-Doping Agency Prohibited List)

Official sources: FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act · FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks · WADA: World Anti-Doping Code International Standard Prohibited List 2026 · WADA: World Anti-Doping Agency Prohibited List · Health Canada: Think twice before injecting peptides bought online: unauthorized products can seriously harm you · Health Canada document 1 · Health Canada document 2 · Health Canada document 3

Report a side effect

If something went wrong after using any product, tell a clinician and report it. Reports are how regulators find contaminated or mislabeled products.

FDA MedWatch (United States)
Canada Vigilance Program (Canada)

Common questions

Is GHK-Cu safe to inject?

Regulator document FDA says there are limited data in humans to inform the safety of injected GHK-Cu, and it flags possible immune reactions from aggregation and peptide-related impurities ^[13]. Health Canada lists GHK-Cu among unauthorized injectable peptides it has seized and warns that such products can lead to infections ^[7]. A 2026 review describes gray-market peptides as having uncertain identity, purity, potency and sterility ^[18].^[13][7][18]

Does GHK-Cu help with hair loss?

A copper-binding peptide, PC1031, enlarged hair follicles on the backs of fuzzy rats, an effect the authors called similar to topical minoxidil ^[10]. AHK-Cu, a related copper tripeptide, lengthened human hair follicles kept alive in a dish ^[11]. In a related human study, a placebo-controlled trial in 45 men (its abstract does not say whether it was randomized) tested a complex of 5-aminolevulinic acid and GHK once daily for 6 months, and hair counts rose more on both strengths than on placebo; the paper names GHK, not GHK-Cu, and the complex has a second active, so the result cannot be credited to GHK-Cu ^[12].^[10][11][12]

Is GHK-Cu FDA approved?

We found no FDA-approved product containing GHK-Cu in Drugs@FDA (searched 2026-10-01). FDA lists GHK-Cu (except for injectable routes of administration) in 503A Category 1, "Bulk Drug Substances Under Evaluation" (list updated 2026-05-14); that is not an approval. FDA's safety page lists injectable GHK-Cu under "Bulk drug substances nominated but withdrawn" and says compounded injectable GHK-Cu may pose a risk of immunogenicity from aggregation and peptide-related impurities. Source: FDA: Drugs@FDA search: ghk-cu — no approved product found; FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act; FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

GHK-Cu vs minoxidil?

Human, small or uncontrolled For copper peptides we found rat and follicle-in-a-dish data, and a 2026 review lists an 18-person split-face eyebrow study of GHK-Cu; we found no human scalp hair-count trial of GHK-Cu. Minoxidil has human trials: a 2022 network meta-analysis compared minoxidil, finasteride and dutasteride across 23 studies in men with pattern hair loss.^{[10][11][17][5]}

Is GHK-Cu banned by WADA?

WADA's Prohibited List does not name GHK-Cu. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether GHK-Cu is one of them. Source: WADA: World Anti-Doping Code International Standard Prohibited List 2026; WADA: World Anti-Doping Agency Prohibited List

References

Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.

Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett (1988). PubMed 3169264 DOI
In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest (1993). PubMed 8227353 DOI
Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Bioimpacts (2025). PubMed 39963574 DOI
A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials. Arch Intern Med Res (2026). PubMed 42787770 DOI
GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. Pharmaceutics (2026). PubMed 42797253 DOI
Permeation behaviour of cosmetic actives into the human stratum corneum. Int J Pharm (2026). PubMed 42790608 DOI
Think twice before injecting peptides bought online: unauthorized products can seriously harm you (Health Canada advisory; lists KPV) Recalls and safety alerts, Government of Canada (2026). Source
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int (2015). PubMed 26236730 DOI
Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation). J Cosmet Laser Ther (2016). PubMed 27064823 DOI
Chemical agents and peptides affect hair growth. J Invest Dermatol (1993). PubMed 8326148 DOI
The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res (2007). PubMed 17703734 DOI
Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Ann Dermatol (2016). PubMed 27489425 DOI
Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks fda.gov (2026). Source
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci (2018). PubMed 29986520 DOI
Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules (2025). PubMed 39795193 DOI
Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res (2011). PubMed 20721598 DOI
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatol (2022). PubMed 35107565 DOI
Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks. Cureus (2026). PubMed 42437212 DOI
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Mo Med (2026). PubMed 42757290

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed. Editorial standards · Evidence grading and update log.